MarketPeel
Insider Trading Intelligence
BR

Brandi Roberts

DFTX
CHIEF FINANCIAL OFFICER · DEFINIUM THERAPEUTICS, INC. · CIK 0001516354
FILING MIX · LIFETIME75%/25%
BUYS
3
SELLS
1
TOTAL VALUE
$135.7K
COMPANIES
2
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
826,187
AVG SELL PX
$45.03
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Brandi Roberts. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
DFTX · 209,487 shares · as of Jun 25, 2026
053,125106,250159,375212,500SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 3 buys / 1 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
DFTX
DEFINIUM THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,013$45.03$135.7K209,487Jun 25, 2026Jun 26, 2026View →
DFTX
DEFINIUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
62,500212,500Jun 22, 2026Jun 22, 2026View →
DFTX
DEFINIUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
150,000150,000Feb 3, 2026Feb 5, 2026View →
LCTX
LINEAGE CELL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
616,700616,700Mar 17, 2020Mar 19, 2020View →
Other insiders · DFTX
Loading peer insiders…
About this filer
CIK 0001516354
ROLE
Chief Financial Officer
PRIMARY
DFTX
COMPANIES
2
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001516354DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback